GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bharat Immunologicals & Biologicals Corp Ltd (BOM:524663) » Definitions » Net Margin %

Bharat Immunologicals & Biologicals (BOM:524663) Net Margin % : 0.00% (As of Sep. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Bharat Immunologicals & Biologicals Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Bharat Immunologicals & Biologicals's Net Income for the three months ended in Sep. 2023 was ₹-49.18 Mil. Bharat Immunologicals & Biologicals's Revenue for the three months ended in Sep. 2023 was ₹0.00 Mil. Therefore, Bharat Immunologicals & Biologicals's net margin for the quarter that ended in Sep. 2023 was 0.00%.

The historical rank and industry rank for Bharat Immunologicals & Biologicals's Net Margin % or its related term are showing as below:

BOM:524663' s Net Margin % Range Over the Past 10 Years
Min: -236.13   Med: -9.05   Max: 5.24
Current: -236.13


BOM:524663's Net Margin % is ranked worse than
55.5% of 1027 companies
in the Biotechnology industry
Industry Median: -154.15 vs BOM:524663: -236.13

Bharat Immunologicals & Biologicals Net Margin % Historical Data

The historical data trend for Bharat Immunologicals & Biologicals's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bharat Immunologicals & Biologicals Net Margin % Chart

Bharat Immunologicals & Biologicals Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.93 -15.28 -21.23 -11.17 -37.30

Bharat Immunologicals & Biologicals Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.64 - -50.66 - -

Competitive Comparison of Bharat Immunologicals & Biologicals's Net Margin %

For the Biotechnology subindustry, Bharat Immunologicals & Biologicals's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bharat Immunologicals & Biologicals's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bharat Immunologicals & Biologicals's Net Margin % distribution charts can be found below:

* The bar in red indicates where Bharat Immunologicals & Biologicals's Net Margin % falls into.



Bharat Immunologicals & Biologicals Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Bharat Immunologicals & Biologicals's Net Margin for the fiscal year that ended in Mar. 2023 is calculated as

Net Margin=Net Income (A: Mar. 2023 )/Revenue (A: Mar. 2023 )
=-166.388/446.091
=-37.30 %

Bharat Immunologicals & Biologicals's Net Margin for the quarter that ended in Sep. 2023 is calculated as

Net Margin=Net Income (Q: Sep. 2023 )/Revenue (Q: Sep. 2023 )
=-49.183/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bharat Immunologicals & Biologicals  (BOM:524663) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Bharat Immunologicals & Biologicals Net Margin % Related Terms

Thank you for viewing the detailed overview of Bharat Immunologicals & Biologicals's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bharat Immunologicals & Biologicals (BOM:524663) Business Description

Traded in Other Exchanges
N/A
Address
Village Chola, BIBCOL, OPV Plant, Bulandshahar, UP, IND, 203203
Bharat Immunologicals & Biologicals Corp Ltd is an India-based biotechnology company. It primarily manufactures Oral polio vaccines. In addition, the company also manufactures zinc tablets, diarrhea management kits, and Ready to Use Therapeutic Food (RUTF). It also manufactures nutraceuticals and biological products for the treatment of health deficiencies and disorders. The firm is organized into three segments: Oral Polio Vaccine, Zinc Tablets, and BIB VIT, BIBSANIT. The group principally operates in India and generates the majority of its revenue from sales of Oral polio vaccines.

Bharat Immunologicals & Biologicals (BOM:524663) Headlines

No Headlines